282 related articles for article (PubMed ID: 35292350)
1. Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis.
Sun R; Zhang Z; Bao R; Guo X; Gu Y; Yang W; Wei J; Chen X; Tong L; Meng J; Zhong C; Zhang C; Zhang J; Sun Y; Ling C; Tong X; Yu FX; Yu H; Qu W; Zhao B; Guo W; Qian M; Saiyin H; Liu Y; Liu RH; Xie C; Liu W; Xiong Y; Guan KL; Shi Y; Wang P; Ye D
J Hepatol; 2022 Aug; 77(2):453-466. PubMed ID: 35292350
[TBL] [Abstract][Full Text] [Related]
2. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
Jiang Y; Han Q; Zhao H; Zhang J
J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.
Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q
J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
Tang SJ; Yang JB
Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
[TBL] [Abstract][Full Text] [Related]
6. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.
Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP
J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516
[TBL] [Abstract][Full Text] [Related]
7. The Transcription of
Gou Y; Yang D; Tian T; Zhu X; Zhang R; Ren J; Tu D; Luo Y; Miao Y; Zhao H; Wang Y; Wei B
Front Immunol; 2022; 13():725595. PubMed ID: 35371096
[TBL] [Abstract][Full Text] [Related]
8. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract][Full Text] [Related]
9. SIRT5 promotes cell proliferation and invasion in hepatocellular carcinoma by targeting E2F1.
Chang L; Xi L; Liu Y; Liu R; Wu Z; Jian Z
Mol Med Rep; 2018 Jan; 17(1):342-349. PubMed ID: 29115436
[TBL] [Abstract][Full Text] [Related]
10. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
11. Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.
Li A; Ji B; Yang Y; Ye B; Zhu Q; Hu X; Liu Y; Zhou P; Liu J; Gao R; Zhou Q; Kang B; Jiang Y
Front Immunol; 2023; 14():1164448. PubMed ID: 37383234
[TBL] [Abstract][Full Text] [Related]
12. The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma.
Lu Y; Sun Q; Guan Q; Zhang Z; He Q; He J; Ji Z; Tian W; Xu X; Liu Y; Yin Y; Zheng C; Lian S; Xu B; Wang P; Jiang R; Sun B
J Hepatol; 2023 Nov; 79(5):1172-1184. PubMed ID: 37473847
[TBL] [Abstract][Full Text] [Related]
13. Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway.
Xu M; Zhou C; Weng J; Chen Z; Zhou Q; Gao J; Shi G; Ke A; Ren N; Sun H; Shen Y
J Exp Clin Cancer Res; 2022 Aug; 41(1):253. PubMed ID: 35986343
[TBL] [Abstract][Full Text] [Related]
14. RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis.
Wu L; Zhang X; Zheng L; Zhao H; Yan G; Zhang Q; Zhou Y; Lei J; Zhang J; Wang J; Xin R; Jiang L; Peng J; Chen Q; Lam SM; Shui G; Miao H; Li Y
Cancer Immunol Res; 2020 May; 8(5):710-721. PubMed ID: 32122992
[TBL] [Abstract][Full Text] [Related]
15. PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.
Wang N; Tan HY; Lu Y; Chan YT; Wang D; Guo W; Xu Y; Zhang C; Chen F; Tang G; Feng Y
Signal Transduct Target Ther; 2021 Feb; 6(1):86. PubMed ID: 33633112
[TBL] [Abstract][Full Text] [Related]
16. Disruption of SLFN11 Deficiency-Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti-PD-1 Therapy Efficacy in Hepatocellular Carcinoma.
Zhou C; Weng J; Liu C; Liu S; Hu Z; Xie X; Gao D; Zhou Q; Sun J; Xu R; Li H; Shen Y; Yi Y; Shi Y; Sheng X; Dong Q; Hung MC; Ren N
Gastroenterology; 2023 Jun; 164(7):1261-1278. PubMed ID: 36863689
[TBL] [Abstract][Full Text] [Related]
17. SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer.
Chen XF; Tian MX; Sun RQ; Zhang ML; Zhou LS; Jin L; Chen LL; Zhou WJ; Duan KL; Chen YJ; Gao C; Cheng ZL; Wang F; Zhang JY; Sun YP; Yu HX; Zhao YZ; Yang Y; Liu WR; Shi YH; Xiong Y; Guan KL; Ye D
EMBO Rep; 2018 May; 19(5):. PubMed ID: 29491006
[TBL] [Abstract][Full Text] [Related]
18. d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma.
Han S; Bao X; Zou Y; Wang L; Li Y; Yang L; Liao A; Zhang X; Jiang X; Liang D; Dai Y; Zheng QC; Yu Z; Guo J
Sci Adv; 2023 Jul; 9(29):eadg2697. PubMed ID: 37467325
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis.
Bonnin M; Fares N; Testoni B; Estornes Y; Weber K; Vanbervliet B; Lefrançois L; Garcia A; Kfoury A; Pez F; Coste I; Saintigny P; Viari A; Lang K; Guey B; Hervieu V; Bancel B; Bartoch B; Durantel D; Renno T; Merle P; Lebecque S
J Hepatol; 2019 Oct; 71(4):763-772. PubMed ID: 31220470
[TBL] [Abstract][Full Text] [Related]
20. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
Yu Z; Li Y; Li Y; Zhang J; Li M; Ji L; Tang Y; Zheng Y; Sheng J; Han Q; Li F; Guo J; Wang L; Sun X; Gao Y; Feng H
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
